why choose us

First received: September 19, 2022

Clinical Trial: Ticagrelor Versus Clopidogrel in Ischemic Stroke

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Ischemic Stroke

Study Type: INTERVENTIONAL


Official Title: Ticagrelor Versus Clopidogrel in Ischemic Stroke. a Randomized Double-blinded Controlled Trial

Brief Summary: Along with the current clinical trial, the efficacy and safety of 180 mg loading dose of ticagrelor administered within the first 24 hours of first-ever ischemic stroke compared to 300 mg clopidogrel were assessed through NIHSS, mRS, duration of hospital stay, and possible adverse effects.

Read more